Bide Pharmatech Co., Ltd. (SHA:688073)
China · Delayed Price · Currency is CNY 74.91
+4.43 (6.29%)
At close: Aug 20, 2026
Bide Pharmatech Market Cap
Bide Pharmatech has a market cap or net worth of 6.07 billion as of August 20, 2026. Its market cap has increased by 16.16% in one year.
Market Cap
6.07B
Enterprise Value
5.13B
Revenue
1.35B
Ranking
n/a
PE Ratio
36.45
Stock Price
74.91
ChartMarket Cap Chart
Since October 11, 2022, Bide Pharmatech's market cap has increased from 4.38B to 6.07B, an increase of 38.76%. That is a compound annual growth rate of 8.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 6.45B | 22.70% |
| Dec 31, 2025 | 5.26B | 21.13% |
| Dec 31, 2024 | 4.34B | -13.91% |
| Dec 29, 2023 | 5.04B | -5.42% |
| Dec 30, 2022 | 5.33B | 21.87% |
| Oct 11, 2022 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dezhan Healthcare Company | 7.24B |
| Guangxi Wuzhou Zhongheng Group | 7.23B |
| Jiangsu Kanion Pharmaceutical | 7.09B |
| China Animal Husbandry Industry | 6.95B |
| HPGC Renmintongtai Pharmaceutical | 6.90B |
| Hainan Haiyao | 6.86B |
| Hunan Er-Kang Pharmaceutical | 6.85B |
| Tianjin Tianyao Pharmaceuticals | 6.72B |